Pulmonary Disease Doctors in Placerville, CA - Medicare Status, Address, Contact

2 Pulmonary Disease doctors found. Showing 1 - 2

Dr. Olena Kotova Lineberry, M.D.
Internal Medicine - Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1004 Fowler Way Ste 4, Placerville, CA 95667
Phone: 530-626-9488

Alexander Halstead Massey, M.D.
Internal Medicine - Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1004 Fowler Way, Ste 4, Placerville, CA 95667
Phone: 530-626-9488 Fax: 530-748-0320

News Archive

Smartphone microscopes could improve detection of skin cancer in developing countries

Everyone knows smartphones can be used as calendars, calculators, radios and cameras. But, did you know they can also be used as microscopes that have the potential to save lives? They are called smartphone microscopes and dermatologists at The University of Texas Health Science Center at Houston think these devices could improve the detection of skin cancer in developing countries.

Largest known series of data examining the sequencing of tamoxifen and radiation

Fox Chase Cancer Center researchers say the sequence of tamoxifen and radiation following lumpectomy for early-stage breast cancer patients does not affect disease control, survival or complication rates, but administering tamoxifen concurrently with radiation has negative cosmetic results.

Results from Merck's vorapaxar study on cardiovascular events

Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.

Research on OGF-OGFr complex helps to understand pathobiology of diseases

Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the Opioid Growth Factor (OGF, [Met5]-enkephalin) and its receptor, OGFr, a clinically important system with potent antitumor properties, has controlled entry from the cytoplasm to the nucleus. The nucleocytoplasmic passage of OGF-OGFr is critical to cell proliferation and suggests that there are hierarchical levels of nuclear import.

Merck receives marketing authorization for ELONVA

Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.

Pulmonary Disease Doctors in Placerville, CA Accepting Medicare